anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 60,557
Current window 32,881-32,910
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all
18 30 60

Component

32,881-32,910 of 60,557

filter-aware
12
The slide uses color-coding to highlight the most recent guidance (August 2021) in blue text.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
21
Includes leadership headshots and disclaimer.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
31
The slide details the financial impact of segment restructuring, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The table tracks financial performance changes for products that have experienced or are anticipating LOE.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units due to patent expirations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
The table tracks financial impact of patent expirations across Bausch & Lomb, Int'l Rx, Salix, Ortho Dermatologics, and Diversified Products.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
The table compares inventory levels between Q1 and Q2 for two consecutive years.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks inventory efficiency across different business segments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
The slide includes a specific callout for organic revenue growth and a disclaimer regarding corporate cost allocation.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
The slide includes a specific callout for +28% organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics like Constant Currency and Organic Change.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The table includes reported, constant currency, and organic change metrics.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
Includes detailed footnotes regarding non-GAAP adjustments and currency impacts.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
Includes footnotes regarding non-GAAP metrics and segment reporting.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The slide highlights a 12% organic growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide highlights a 10% organic revenue growth for the International Rx segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The slide includes a specific callout for Global Solta's organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics like EBITA and organic change.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
The table tracks revenue in millions for 10 products from 2Q20 to 2Q21.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
The table provides a comparative view of product revenue across five quarters (2Q20 to 2Q21).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
The table tracks 10 products across 5 quarters, totaling 50 data points.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
The table tracks revenue in millions for 10 products across 5 quarters (2Q20 to 2Q21).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
57
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table lists 10 products with their respective revenue figures for 2Q21, 1Q21, 4Q20, 3Q20, and 2Q20.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table reconciles net loss to adjusted net income (non-GAAP) by detailing specific adjustments like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
61
The table provides a breakdown of specific financial line items for Bausch + Lomb, likely for reconciliation or segment reporting purposes.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit